Peloton Wealth Strategists - 4D MOLECULAR THERAPEUTICS IN ownership

Quarter-by-quarter ownership
Peloton Wealth Strategists ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$318
+15.6%
25,000
+56.2%
0.15%
+16.7%
Q1 2023$275
-66.5%
16,000
-56.8%
0.13%
-68.2%
Q4 2022$822
-99.8%
37,000
-27.5%
0.40%
+85.9%
Q3 2022$410,000
+91.6%
51,000
+66.6%
0.21%
+104.8%
Q2 2022$214,00030,6140.10%
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 1,566,895$23,691,0005.12%
Aquilo Capital Management, LLC 1,755,506$26,543,0003.90%
Deep Track Capital, LP 2,448,200$37,017,0002.37%
BVF INC/IL 2,664,521$40,288,0001.61%
Opaleye Management Inc. 325,000$4,914,0001.53%
Perigon Wealth Management, LLC 557,475$8,429,0000.60%
Eagle Health Investments LP 132,090$1,997,0000.49%
Casdin Capital, LLC 555,455$8,398,0000.38%
VIKING GLOBAL INVESTORS LP 3,937,914$59,541,0000.24%
ArrowMark Colorado Holdings LLC 1,145,585$17,321,0000.15%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders